VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-01810
Package ID: USCOURTS-cofc-1_18-vv-01810
Petitioner: Daisy M. Honaker
Filed: 2018-11-26
Decided: 2021-09-01
Vaccine: influenza
Vaccination date: 2017-10-23
Condition: complex regional pain syndrome (“CRPS”) and ulnar neuropathy secondary to CRPS
Outcome: compensated
Award amount USD: 150000

AI-assisted case summary:
On November 26, 2018, Daisy M. Honaker filed a petition under the National Vaccine Injury Compensation Program, alleging that she developed complex regional pain syndrome (CRPS) and ulnar neuropathy secondary to CRPS as a result of an influenza vaccine she received on October 23, 2017. The respondent, the Secretary of Health and Human Services, denied that the flu vaccine caused the petitioner's alleged conditions. Despite maintaining their respective positions, both parties entered into a joint stipulation to settle the case and award compensation. Special Master Katherine E. Oler reviewed the stipulation and found it to be reasonable, adopting it as the decision of the court. The stipulation awarded Ms. Honaker a lump sum of $150,000.00, payable by check, as compensation for all damages. The decision was issued on September 1, 2021. David Tierney represented the petitioner, and Althea Davis represented the respondent.

Theory of causation field:
Petitioner Daisy M. Honaker received an influenza vaccine on October 23, 2017, and subsequently developed complex regional pain syndrome (CRPS) and ulnar neuropathy secondary to CRPS. The respondent denied that the vaccine caused these conditions. The parties entered into a stipulation to settle the case, and Special Master Katherine E. Oler adopted the stipulation as her decision. The stipulation awarded petitioner a lump sum of $150,000.00 for all damages. The public decision does not describe the specific theory of causation, medical experts, onset, symptoms, tests, treatments, or the mechanism of injury. The attorneys involved were David Tierney for the petitioner and Althea Davis for the respondent. The decision date was September 1, 2021.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-01810-0
Date issued/filed: 2021-09-01
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 7/20/2021) regarding 33 DECISION of Special Master - Stipulation. Signed by Special Master Katherine E. Oler. (sl) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-01810-UNJ Document 39 Filed 09/01/21 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 18-1810V
(not to be published)
* * * * * * * * * * * * * * * * * * * * * * * * * *
*
*
DAISY M. HONAKER,
*
* Filed: July 20, 2021
Petitioner, *
*
*
v. * Decision by Stipulation; Damages;
* Influenza (“Flu”) Vaccine; Chronic
SECRETARY OF HEALTH AND * Regional Pain Syndrome (“CRPS”); Ulnar
HUMAN SERVICES, * Neuropathy Secondary to CRPS.
*
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * *
David Tierney, Rawls Law Group, Richmond, VA, for Petitioner
Althea Davis, U.S. Department of Justice, Washington, DC, for Respondent
DECISION ON JOINT STIPULATION1
On November 26, 2018, Daisy Honaker (“Petitioner”) filed a petition, seeking
compensation under the National Vaccine Injury Compensation Program (“the Vaccine
Program”).2 Pet., ECF No. 1. Petitioner alleges she developed complex regional pain syndrome
(“CRPS”) and ulnar neuropathy secondary to CRPS as a result of the influenza (“flu”) vaccination
she received on October 23, 2017. See Stipulation ¶ 2, 4, dated July 20, 2021 (ECF No. 32); see
also Petition.
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the Decision will be available to anyone with access to the internet. As
provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of
certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen
days within which to request redaction “of any information furnished by that party: (1) that is a trade secret
or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.”
Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter
“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
pertinent subparagraph of 42 U.S.C. § 300aa.

Case 1:18-vv-01810-UNJ Document 39 Filed 09/01/21 Page 2 of 7
Respondent denies “that petitioner’s alleged CRPS, ulnar neuropathy, or any other injury
or condition were caused by the flu vaccine.” See Stipulation ¶ 6. Nonetheless, both parties, while
maintaining their above-stated positions, agreed in a stipulation filed July 20, 2021 that the issues
before them can be settled and that a decision should be entered awarding Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
therein.
The stipulation awards:
a lump sum of $150,000.00 in the form of a check payable to petitioner.
Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a).
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk
of the Court is directed to enter judgment herewith.3
IT IS SO ORDERED.
s/ Katherine E. Oler
Katherine E. Oler
Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
renouncing their right to seek review.

Case 1:18-vv-01810-UNJ Document 39 Filed 09/01/21 Page 3 of 7

Case 1:18-vv-01810-UNJ Document 39 Filed 09/01/21 Page 4 of 7

Case 1:18-vv-01810-UNJ Document 39 Filed 09/01/21 Page 5 of 7

Case 1:18-vv-01810-UNJ Document 39 Filed 09/01/21 Page 6 of 7

Case 1:18-vv-01810-UNJ Document 39 Filed 09/01/21 Page 7 of 7